Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

IT0005274094
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG00H5FW2L0
PHN

Pharmanutra SpA
GICS: Consumer Staples · SECTOR: EQTY · SUB-SECTOR: - · THEMEFOLIO: $STPL
NAME
Pharmanutra SpA
ISIN
IT0005274094
TICKER
PHN
MIC
XMIL
REUTERS
PHNU.MI
BLOOMBERG
PHN IM
Sun, 03.05.2026       Pharmanutra

Das Instrument 761 IT0005274094 PHARMANUTRA S.P.A. EQUITY wird ex Dividende/Zinsen gehandelt am 04.05.2026 The instrument 761 IT0005274094 PHARMANUTRA S.P.A. EQUITY has its ex-dividend/interest day on 04.05.2026...
Tue, 25.03.2025       Pharmanutra

THE GROUP'S PATENTED AND DESIGNED SOLUTION INDICATED AS THE ONLY ORAL IRON FOR ANAEMIA IN PEOPLE WITH CARDIOVASCULAR DISEASE AND DIABETES PISA, Italy, March 25, 2025 /PRNewswire/ -- PharmaNutra S.p.A. (MTA:PHN), a company specializing in the field of iron and mineral nutritional supplements and medical devices for muscles and joints, announces th...
Tue, 25.03.2025       Pharmanutra

THE GROUP'S PATENTED AND DESIGNED SOLUTION INDICATED AS THE ONLY ORAL IRON FOR ANAEMIA IN PEOPLE WITH CARDIOVASCULAR DISEASE AND DIABETES PISA, Italy, March 25, 2025 /PRNewswire/ -- PharmaNutra S.p.A. (MTA:PHN), a company specializing in the field of iron and mineral nutritional supplements and medical devices for muscles and joints, announces th...
Tue, 25.03.2025       Pharmanutra

THE GROUP'S PATENTED AND DESIGNED SOLUTION INDICATED AS THE ONLY ORAL IRON FOR ANAEMIA IN PEOPLE WITH CARDIOVASCULAR DISEASE AND DIABETES PISA, Italy, March 25, 2025 /CNW/ -- PharmaNutra S.p.A. (MTA:PHN), a company specializing in the field of iron and mineral nutritional supplements and medical devices for muscles and joints, announces that oral...
Sun, 05.05.2024       Pharmanutra

Das Instrument 761 IT0005274094 PHARMANUTRA S.P.A. EQUITY wird ex Dividende/Zinsen gehandelt am 06.05.2024 The instrument 761 IT0005274094 PHARMANUTRA S.P.A. EQUITY has its ex-dividend/interest day on 06.05.2024...
Thu, 02.05.2024       Pharmanutra

Das Instrument 761 IT0005274094 PHARMANUTRA S.P.A. EQUITY wird cum Dividende/Zinsen gehandelt am 03.05.2024 und ex Dividende/Zinsen am 06.05.2024 The instrument 761 IT0005274094 PHARMANUTRA S.P.A. EQUITY has its pre-dividend/interest day on 03.05.2024 and its ex-dividend/interest day on 06.05.2024...